Log in to save to my catalogue

ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2376808

ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

About this item

Full title

ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

Publisher

London: Nature Publishing Group UK

Journal title

Nature cell biology, 2008-02, Vol.10 (2), p.138-148

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The RAS–ERK pathway is known to play a pivotal role in differentiation, proliferation and tumour progression. Here, we show that Erk downregulates Forkhead box O 3a (FOXO3a) by directly interacting with and phosphorylating FOXO3a at Ser 294, Ser 344 and Ser 425, which consequently promotes cell proliferation and tumorigenesis. The ERK-phosphorylate...

Alternative Titles

Full title

ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2376808

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2376808

Other Identifiers

ISSN

1465-7392

E-ISSN

1476-4679

DOI

10.1038/ncb1676

How to access this item